These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7079291)

  • 1. Effects of drug pretreatment on antipyrine elimination in the rabbit.
    Chambers DM; Jefferson GC
    Pharmacology; 1982; 24(2):88-95. PubMed ID: 7079291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.
    Chindavijak B; Belpaire FM; Bogaert MG
    Pharmacology; 1988; 36(4):279-82. PubMed ID: 3380881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antipyrine metabolite formation in rats in vivo.
    Rhodes JC; Hall ST; Houston JB
    Xenobiotica; 1984 Sep; 14(9):677-86. PubMed ID: 6516440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S; Nielsen AJ; Borg BE; Poulsen HE
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 7. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent effect of propafenone on in vivo drug metabolism in the rat.
    Chong MT; Svensson CK
    Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):147-56. PubMed ID: 3423421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of antipyrine sulphoconjugates in isolated cultured rat hepatocytes.
    Palette C; Dubor F; Rovei V; Advenier C
    Xenobiotica; 1993 Feb; 23(2):181-91. PubMed ID: 8498081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monthly variations in the clearance of antipyrine in the rat.
    Bélanger PM; Doré F; Labrecque G
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKF 525-A inhibition of hepatic monooxygenase activity in rhesus monkeys.
    Clark CR; Gee SJ; Krieger RI
    Pharmacology; 1978; 17(4):201-9. PubMed ID: 99753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent pharmacokinetics of antipyrine in the rat.
    Pollack GM; Li RC; Shen DD
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of anti-cancer drugs on pharmacokinetics of antipyrine in vitamin A deficiency.
    Khanduja KL; Dogra SC; Kaushal S; Sharma RR
    Biochem Pharmacol; 1984 Feb; 33(3):449-52. PubMed ID: 6704163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat.
    Venkataramanan R; Axelson JE
    J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species- and sex-related differences in the plasma clearance and metabolite formation of antipyrine. A comparative study in four animal species: cattle, goat, rat and rabbit.
    Witkamp RF; Lohuis JA; Nijmeijer SM; Kolker HJ; Noordhoek J; van Miert AS
    Xenobiotica; 1991 Nov; 21(11):1483-92. PubMed ID: 1763522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
    Breimer DD; Zilly W; Richter E
    Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some observations on the mechanism of benzodiazepine-barbiturate interactions in the mouse.
    Chambers DM; Jefferson GC
    Br J Pharmacol; 1977 Jul; 60(3):393-9. PubMed ID: 19117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat.
    Svensson CK; Liu LL; Knowlton PW
    Pharm Res; 1987 Jun; 4(3):251-4. PubMed ID: 3509291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.